Literature DB >> 13433397

The genesis of intestinal atresia.

C N BARNARD.   

Abstract

Entities:  

Keywords:  INTESTINES/abnormalities

Mesh:

Year:  1957        PMID: 13433397

Source DB:  PubMed          Journal:  Surg Forum        ISSN: 0071-8041


× No keyword cloud information.
  8 in total

1.  RESISTANCE to insecticides.

Authors: 
Journal:  Br Med J       Date:  1959-09-19

2.  Recent developments in the management of gastrointestinal malformations.

Authors:  E W Fonkalsrud
Journal:  Calif Med       Date:  1967-06

3.  A study of the aetiology of congenital stenosis of the gut.

Authors:  R J Earlam
Journal:  Ann R Coll Surg Engl       Date:  1972-08       Impact factor: 1.891

4.  Lack of discreet colocalization of epithelial apoptosis to the atretic precursor in the colon of the Fibroblast growth factor receptor 2IIIb mouse and staining consistent with cellular movement suggest a revised model of atresia formation.

Authors:  Anna Kowalkowski; Krzysztof M Zaremba; Andrew P Rogers; Olivia R Hoffman; Anne E Turco; Peter F Nichol
Journal:  Dev Dyn       Date:  2020-03-10       Impact factor: 3.780

5.  Haploinsufficiency of retinaldehyde dehydrogenase 2 decreases the severity and incidence of duodenal atresia in the fibroblast growth factor receptor 2IIIb-/- mouse model.

Authors:  Amy L Reeder; Robert A Botham; Krzysztof M Zaremba; Peter F Nichol
Journal:  Surgery       Date:  2012-10       Impact factor: 3.982

6.  A vascular cause for aganglionic bowel. A new hypothesis.

Authors:  R J Earlam
Journal:  Am J Dig Dis       Date:  1972-03

Review 7.  Humans, mice, and mechanisms of intestinal atresias: a window into understanding early intestinal development.

Authors:  Peter F Nichol; Amy Reeder; Robert Botham
Journal:  J Gastrointest Surg       Date:  2010-11-30       Impact factor: 3.452

8.  Adriamycin produces a reproducible teratogenic model of gastrointestinal atresia in the mouse.

Authors:  Michael J Dawrant; Shay Giles; John Bannigan; Prem Puri
Journal:  Pediatr Surg Int       Date:  2008-04-05       Impact factor: 1.827

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.